News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
CAR-T therapy developer Kite Pharma has licensed rights to a culturing system that replicates conditions in the thymus from researchers at the University of California.
Fresh from completing an off-the-shelf JHL plant and signing a $350m facility deal with Pfizer, GE believes modular bioprocessing could be the future.
update
Epirus Biopharmaceuticals has filed for Chapter 7 bankruptcy protection, settled with licensee Livzon Mabpharm and handed its Remicade (infliximab) biosimilar to Reliance Life Sciences (RLS).